In this article (Clin Cancer Res 2005;11:2111–22), which was published in the March 15, 2005, issue of Clinical Cancer Research (1), several images in Figs. 2A, 3A, and 4A were inadvertently duplicated by the authors. The authors repeated the experiments represented in the abovementioned figures. Western blot studies in endocrine sensitive and insensitive breast cancer cells confirmed an upregulation of the transcription factors Ets-1 and Ets-2 and the coactivator SRC-1 in response to treatment with EGF. In addition, immunoprecipitation studies confirmed interactions between Ets-1 and SRC-1, as well as N-CoR and interactions between Ets-2 and N-CoR. The authors claim that these experiments confirm the results presented in the original article. The corrected versions of Figs. 2A, 3A, and 4A are below. The authors regret this error.
Corrections| April 30 2015
Correction: Associations and Interactions between Ets-1 and Ets-2 and Coregulatory Proteins, SRC-1, AIB1, and NCoR in Breast Cancer
Online Issn: 1557-3265
Print Issn: 1078-0432
©2015 American Association for Cancer Research.
Clin Cancer Res (2015) 21 (9): 2190–2191.
- Views Icon Views
- Share Icon Share
- Search Site
Article Versions Icon
- Version of Record April 30 2015
Correction: Associations and Interactions between Ets-1 and Ets-2 and Coregulatory Proteins, SRC-1, AIB1, and NCoR in Breast Cancer. Clin Cancer Res 1 May 2015; 21 (9): 2190–2191. https://doi.org/10.1158/1078-0432.CCR-15-0405
Download citation file: